NCT02297529 2019-10-31Expanded Access Study of Talimogene Laherparepvec for Treatment of Subjects With Unresected Stage IIIB-IVM1c MelanomaAmgenNo longer available
NCT02147951 2016-03-01Expanded Access Protocol of Talimogene Laherparepvec for Subjects With Unresected, Stage lllB to IVM1c MelanomaAmgenNo longer available